Skip to main content

Keenova Therapeutics plc

MNKTQDelisted Sep 6, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001567892

Keenova Therapeutics plc was delisted on Sep 6, 2023; its insiders filed their last Form 4 on Jul 23, 2026; 36 institutions reported holding it in 13F filings for Q2 2023, worth $12.4M in total; no superinvestor held it.

13F holders, Q2 2021

Institutional positions in Keenova Therapeutics plc as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
11
−10 vs. Q1 2021
Shares held
223.7K
−3.13K (−1.4%) vs. Q1 2021
Total value
$64.2K
−$20.1K (−23.9%) vs. Q1 2021
New holders
2
1 more added
Sold out
12
3 more reduced

Compare with Q1 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting MNKTQ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2021: 11 institutions
Q1 2021: 21 institutionsQ2 2021: 11 institutionsQ3 2021: 10 institutionsQ4 2021: 12 institutionsQ1 2022: 10 institutionsQ2 2022: 3 institutionsQ3 2022: 3 institutionsQ4 2022: 47 institutionsQ1 2023: 45 institutionsQ2 2023: 36 institutionsQ3 2023: 4 institutionsQ4 2023: 1 institutionQ1 2024: 1 institutionQ2 2024: 1 institutionQ3 2024: 1 institutionQ4 2024: 1 institutionQ1 2025: 1 institutionQ2 2025: 1 institutionQ3 2025: 1 institutionQ4 2025: 1 institutionQ1 2026: 1 institutionQ2 2026: 1 institution
Value heldQ2 2021: $64.2K
Q1 2021: $84.3KQ2 2021: $64.2KQ3 2021: $4.15KQ4 2021: $8.09KQ1 2022: $8.07KQ2 2022: $1.21MQ3 2022: $889.0KQ4 2022: $80.5MQ1 2023: $75.2MQ2 2023: $12.4MQ3 2023: $12.5KQ4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding MNKTQ and their total value by quarter
QuarterHoldersValue
Q2 20261$0
Q1 20261$0
Q4 20251$0
Q3 20251$0
Q2 20251$0
Q1 20251$0
Q4 20241$0
Q3 20241$0
Q2 20241$0
Q1 20241$0
Q4 20231$0
Q3 20234$12.5K
Q2 202336$12.4M
Q1 202345$75.2M
Q4 202247$80.5M
Q3 20223$889.0K
Q2 20223$1.21M
Q1 202210$8.07K
Q4 202112$8.09K
Q3 202110$4.15K
Q2 202111$64.2K
Q1 202121$84.3K

Institutions, Q2 2021

Shares, value and share of portfolio for each institution holding Keenova Therapeutics plc; share changes are against Q1 2021.

Institutions holding MNKTQ in Q2 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Gagnon Securities LLC218,143$63.0K0.01%−157−0.1%Reduced
Meeder Asset Management Inc3,131$1.00K0.00%00.0%Unchanged
Estabrook Capital Management734$2130.00%−143−16.3%Reduced
Huntington National Bank46$00.00%00.0%Unchanged
Captrust Financial Advisors557$00.00%+524+1,587.9%Added
Highlander Capital Management, LLC1,000$00.00%00.0%Unchanged
Lowe Wealth Advisors, LLC1$00.00%00.0%Unchanged
IFP Advisors, Inc8$00.00%00.0%Unchanged
Freedman Financial Associates, Inc.12$00.00%−688−98.3%Reduced
Steward Partners Investment Advisory, LLC101$00.00%+101New
Front Row Advisors LLC15$00.00%+15New
Valeo Financial Advisors, LLC0$00.00%−2,268−100.0%Sold out
Trust Co of Vermont0$00.00%−50−100.0%Sold out
AdvisorNet Financial, Inc0$00.00%−30−100.0%Sold out
Sonora Investment Management, LLC0$00.00%−200−100.0%Sold out
Carroll Financial Associates, Inc.0$00.00%−7−100.0%Sold out
Parallel Advisors, LLC0$00.00%−3−100.0%Sold out
Coastal Capital Group, Inc.0$00.00%−33−100.0%Sold out
Savior LLC0$00.00%−6−100.0%Sold out
Eudaimonia Partners, LLC0$00.00%−126−100.0%Sold out
Walled Lake Planning & Wealth Management, LLC0$00.00%−15−100.0%Sold out
Hexagon Capital Partners LLC0$00.00%−19−100.0%Sold out
Clearview Wealth Advisors LLC0$00.00%−28−100.0%Sold out